Senates, E. Et Al. 2012. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. MINERVA MEDICA , vol.103, no.5 , 369-376.

Senates, E., COLAK, Y., YESIL, A., Coskunpinar, E., Şahin, O. A., Kahraman, O. T., ... SENATES, B. E.(2012). Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. MINERVA MEDICA , vol.103, no.5, 369-376.

Senates, E. Et Al. "Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores," MINERVA MEDICA , vol.103, no.5, 369-376, 2012

Senates, E. Et Al. "Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores." MINERVA MEDICA , vol.103, no.5, pp.369-376, 2012

Senates, E. Et Al. (2012) . "Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores." MINERVA MEDICA , vol.103, no.5, pp.369-376.

@article{article, author={E. Senates Et Al. }, title={Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores}, journal={MINERVA MEDICA}, year=2012, pages={369-376} }